Advertisement
Screener

VERU INC. (VERU) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Shares Authorized

VERU INC. (VERU) had Shares Authorized of 308.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-10

  • 2026-06-30: Common Stock, Shares Authorized 308.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 308.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 308.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 308.00M shares.
Period endCommon Stock, Shares Authorized
2026-06-30308.00M shares
10-Q · filed 2026-08-10
2026-03-31308.00M shares
10-Q · filed 2026-05-13
2025-12-31308.00M shares
10-Q · filed 2026-02-11
2025-09-30308.00M shares
10-Q · filed 2026-08-10
2025-06-30308.00M shares
10-Q · filed 2025-08-12
2025-03-31308.00M shares
10-Q · filed 2025-05-08
2024-12-31308.00M shares
10-Q · filed 2025-02-13
2024-09-30308.00M shares
10-K · filed 2025-12-17
2024-06-30308.00M shares
10-Q · filed 2024-08-08
2024-03-31308.00M shares
10-Q · filed 2024-05-08
2023-12-31308.00M shares
10-Q · filed 2024-04-01
2023-09-30308.00M shares
10-K · filed 2024-12-16
2023-06-30154.00M shares
10-Q/A · filed 2023-11-15
2023-03-31154.00M shares
10-Q · filed 2023-05-11
2022-12-31154.00M shares
10-Q · filed 2023-02-09
2022-09-30154.00M shares
10-K/A · filed 2024-04-01
2022-06-30154.00M shares
10-Q · filed 2022-08-11
2022-03-31154.00M shares
10-Q · filed 2022-05-12
2021-12-31154.00M shares
10-Q · filed 2022-02-09
2021-09-30154.00M shares
10-K · filed 2022-12-05
2021-06-30154.00M shares
10-Q · filed 2021-08-12
2021-03-31154.00M shares
10-Q · filed 2021-05-12
2020-12-31154.00M shares
10-Q · filed 2021-02-10
2020-09-30154.00M shares
10-K · filed 2021-12-02
2020-06-30154.00M shares
10-Q · filed 2020-08-13
2020-03-31154.00M shares
10-Q · filed 2020-05-13
2019-12-31154.00M shares
10-Q · filed 2020-02-12
2019-09-30154.00M shares
10-K · filed 2020-12-10
2019-06-30154.00M shares
10-Q · filed 2019-08-08
2019-03-31154.00M shares
10-Q · filed 2019-05-15
2019-03-27154.00M shares
10-Q · filed 2020-02-12
2019-03-2677.00M shares
10-K · filed 2020-12-10
2018-12-3177.00M shares
10-Q · filed 2019-02-13
2018-09-3077.00M shares
10-K · filed 2019-12-12
2017-09-3077.00M shares
10-K · filed 2018-12-13
2016-09-3038.50M shares
10-K · filed 2018-12-13
2015-09-3038.50M shares
10-K · filed 2016-12-12
2014-09-3038.50M shares
10-K · filed 2015-12-02
2013-09-3038.50M shares
10-K · filed 2014-12-02
2012-09-3038.50M shares
10-K · filed 2013-12-03
2011-09-3038.50M shares
10-K · filed 2012-12-04
2010-09-3038.50M shares
10-K · filed 2011-12-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34